Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
| 5VOB | S6B291 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
| 5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
| 5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
| 5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | |
| 5VNC | P27472 | Glycogen synthase in complex with UDP and glucosamine | |
| 5VN8 | B3UEZ6 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN8 | B3UES2 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN8 | 5VN8 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN4 | Q57V32 | Crystal structure of adenine phosphoribosyl transferase from Trypanosoma brucei in complex with AMP, pyrophosphate, and ribose-5-phosphate | |
| 5VN3 | B3UEZ6 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VN3 | P01730 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VN3 | B3UES2 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VN3 | 5VN3 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VMJ | Q9WFX4 | Influenza hemagglutinin H1 mutant DH1E in complex with 3'SLN | |
| 5VMJ | Q9WFX3 | Influenza hemagglutinin H1 mutant DH1E in complex with 3'SLN | |
| 5VMG | Q9WFX4 | Influenza hemagglutinin H1 mutant DH1E in complex with 6'SLN | |
| 5VMG | Q9WFX3 | Influenza hemagglutinin H1 mutant DH1E in complex with 6'SLN | |
| 5VMF | Q9WFX3 | Influenza hemagglutinin H1 mutant DH1D in complex with 6'SLN | |
| 5VME | Q6MZV7 | Crystal structure of human IgG1 Fc K248E, T437R mutant | |
| 5VMC | Q9WFX3 | Influenza hemagglutinin H1 mutant DH1 in complex with 6'SLN | |
| 5VMA | A8FDC4 | Structure of B. pumilus GH48 in complex with a cellobio-derived isofagomine | |
| 5VLI | P03452 | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
| 5VLI | 5VLI | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
| 5VL3 | S6B291 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | S6B291 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | Q8TCD0 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VL3 | P20273 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | |
| 5VKS | A7YCM0 | Crystal structure of P[19] rotavirus VP8* complexed with LNFPI | |
| 5VKM | P20273 | Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose | |
| 5VKJ | P20273 | Crystal structure of human CD22 Ig domains 1-3 | |
| 5VKI | A7YCM0 | Crystal structure of P[19] rotavirus VP8* complexed with mucin core 2 | |
| 5VK2 | P08669 | Structural basis for antibody-mediated neutralization of Lassa virus | |
| 5VK2 | 5VK2 | Structural basis for antibody-mediated neutralization of Lassa virus | |
| 5VJM | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTa | |
| 5VJL | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTc | |
| 5VJK | R4NN21 | Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) | |
| 5VIY | Q2N0S6 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIF | O15294 | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase |
